Search
for
Sort by
Research 61–90 of 1000+
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Polycystic ovary syndrome: a dermatologic approach
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Platelet Immune Interactions, Lifespan, and Senescence
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Global Research Trends for Platelet-Rich Plasma: A Science Mapping with Machine Learning Techniques
- Immunomodulatory Effects of Platelet-Rich Plasma (PRP) on Neuroinflammation: Insights from B92 Glial Cells Stimulated with Heat-Killed Escherichia coli
- Evaluation of intralesional injection of platelet derived growth factors PDGF ma in patients with Peyronie's disease
- Parry Romberg Syndrome: When the Diagnosis of a Rare Disease Is Made in the Primary Care Setting
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Triple-Negative Sjogren’s Syndrome and Recurrent Pneumothorax: An Uncommon Presentation of Autoimmune Disease
- Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Versatility of autologous growth factor concentrate therapy in early-stage androgenetic alopecia: A case report
- Is skin microneedling a good alternative method of various skin defects removal
- Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine
- Testosterone Treatment in Women – An Overview
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Current and future pharmacotherapy for alopecia areata
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups